PATENT CLAIM ANALYSIS

Application Number: 15970563
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "147100"]

Abstract:
The present invention provides a composite comprising a novel antibody and at least one selected from the group consisting of a solid phase support and a labeled substance. The antibody consists of the amino acid sequence represented by SEQ ID NO: 08, and is capable of binding to an intranuclear protein of an influenza virus type A. The influenza virus type A is at least one selected from the group consisting of H1N1, H2N2, H3N2, and H7N9. The antibody is bound to the at least one selected from the group consisting of the solid phase support and the labeled substance. The present invention also provides a detection device and a detection method using the composite.

Claim (Index 3):
The antibody according to  claim 1 , wherein\n the FR1, the FR2, the FR3, and the FR4 consist of amino acid sequences represented by QVQLVESGGGLVQAGGSLRLSCAAS (SEQ ID NO: 04), WYRQAPGKQRELVA (SEQ ID NO: 05), RFTISRDNAKNTMYLQMNSLKPEDTAVYYCNT (SEQ ID NO: 06), and WGQGAQVTVSS (SEQ ID NO: 07), respectively.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 2.15517
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15970597', '15648287', '15649279', '14995902', '15388196']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7883911482493812
- 35 USC 102 Novelty (BERT): 0.6242120174295716
- Combined Prediction Score: 0.7719732351674002
- Mean Citation Score: 497.725958
- Max Citation Score: 567.8446700000002
- Similarity Product: 523.7627284489466

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test